2026-01-31
中国女博士便携式MRI研发获全球唯一顶级大奖 Chinese Female PhD’s Portable MRI Wins World’s Only Top Award
2025年普林斯-米尼转化科学奖唯一获奖者——中国青年科学家凭借便携式核磁共振设备研发获奖，该设备可将MRI成本降低90%，有望改变全球医学影像格局。 The 2025 Prince-Meany Translational Science Award winner — a young Chinese scientist received the award for developing a portable MRI device that reduces costs by 90%, set to transform global medical imaging.
2026-01-13
中国首款下一代TRK抑制剂获批：肿瘤缩小率达90% China’s 1st Next-Gen TRK Inhibitor Approved: 90% Tumor Shrinkage
国家药品监督管理局正式批准首款下一代泛癌种TRK抑制剂注册申请，对NTRK基因融合阳性实体瘤患者显示高达90%的肿瘤缩小率。 China’s NMPA approved the first next-generation pan-cancer TRK inhibitor, demonstrating 90% tumor shrinkage in NTRK fusion-positive solid tumor patients.
2026-01-12
中国支持突破性新药：针对HER2突变肺癌获批 China-Backed Breakthrough: New Drug for HER2-Mutant Lung Cancer Approved
针对HER2突变的创新口服药Zongertinib正式获批，为HER2突变非小细胞肺癌患者提供了新的靶向治疗选择，填补了该领域的治疗空白。 Innovative oral drug Zongertinib targeting HER2 mutations was officially approved, providing a new targeted therapy option for HER2-mutant NSCLC patients.
2025-12-20
中国CAR-T治疗再获突破：覆盖血液肿瘤全部主要病种 China CAR-T Breakthrough: Coverage Expanded to All Major Hematologic Cancers
中国CAR-T细胞治疗产品相继获批上市，覆盖白血病、淋巴瘤、骨髓瘤等主要血液肿瘤，中国已成为全球CAR-T细胞疗法临床试验最为活跃的国家。 China’s CAR-T cell therapy products have been successively approved, covering leukemia, lymphoma, myeloma and other major hematologic cancers. China is now the most active country in CAR-T clinical trials globally.
2025-12-05
中国人工智能辅助诊断系统获FDA突破性设备认定 China AI Diagnostic System Receives FDA Breakthrough Device Designation
中国某科技企业开发的AI辅助胰腺癌早期筛查系统获得美国FDA突破性设备认定，成为首个获得该认定的中国AI医疗设备。 An AI-assisted pancreatic cancer early screening system developed by a Chinese tech company received FDA Breakthrough Device Designation — the first such designation for a Chinese AI medical device.
2025-11-18
世界卫生组织正式将中医药纳入全球医学纲要 WHO Officially Includes Traditional Chinese Medicine in Global Medical Guidelines
世卫组织在其最新发布的国际疾病分类第十一版（ICD-11）中正式纳入中医药章节，标志着中医药在全球医学体系中的地位得到历史性提升。 The WHO officially included Traditional Chinese Medicine in ICD-11, marking a historic elevation of TCM’s status in the global medical system.